Latest News
Kirkland & Ellis has appointed Manas Chandrashekar as a partner in the firm’s Debt Finance Practice Group.
Callan, a leading institutional investment consulting firm, has released its Private Equity Fees and Terms Study today, which analyses the fees and terms for 90 private equity partnerships to help institutional investors evaluate, and even negotiate, a partnership’s terms.“We created this study to help investors evaluate a partnership’s terms compared to those of its peers, which is an especially useful tool when conducting due diligence,” says Pete Keliuotis, head of alternatives consulting at Callan. “We also envision that general partners may find the study useful as a way to benchmark their partnership terms.”
The study, which leverages Callan’s proprietary
CenterOak Partners’ portfolio company Service Champions has acquired ABC Cooling Heating & Plumbing (ABC), a provider of residential air conditioning and plumbing repair services headquartered in Hayward, California. ABC has provided high quality service to homeowners across the greater East Bay metropolitan area for over 65 years.
This transaction marks Service Champion’s fifth acquisition since CenterOak completed a majority investment in May 2019 and expands Service Champion’s residential service agreement base to over 45,000 across the state of California.
“We are excited to expand our footprint into the East Bay and solidify our position as the largest residential services
Sidley Austin has appointed Nicolai Schwarz-Gondek as a partner in the firm’s private equity practice in Century City. Schwarz-Gondek, who was previously a partner at O’Melveny & Myers LLP, concentrates his practice on private equity and M&A transactions, with a particular focus on the representation of private equity sponsors and other institutional investors in connection with mergers, stock and asset acquisitions and divestitures, and leveraged and management buyouts. He also represents target and acquiring companies, including the portfolio companies of private equity firms, in a broad range of M&A transactions. His practice has included a variety of industries, such as information
Evertas, a cryptoasset insurance company, has completed a USD2.8 million seed stage funding round. The funding round was led by Morgan Creek, who were joined by Plug n Play, Kailash Ventures, RenGen, Vy Capital and Wavemaker Genesis. Mark Yusko, Founder, CEO and Chief Investment Officer of Morgan Creek Capital Management & Managing Partner of Morgan Creek Digital Assets, has joined Evertas’ Board of Directors.
Evertas, which focuses on covering institutional holders of cryptoassets including exchanges, custodians, traditional financial institutions, funds, family offices and ultra-high net worth individuals, will be using these funds to support its strong growth plans.
The market capitalisation of cryptoassets is around USD270 billion and growing rapidly, but because of the highly specialised nature of underwriting the risks
Rochester Institute of Technology (RIT) has become the first US university to invest in Cosimo Ventures’s new, blockchain-focused tokenised fund, Cosimo X.
Based in Boston and Dublin, Cosimo Ventures is an investment firm focused on deep tech companies. This is the first time that any university in the US has invested directly in a tokenised venture fund.
Harvard, Yale and MIT have all made indirect investments into digital assets and blockchain tech through traditional venture funds previously, such as Andreesen Horowitz and Paradigm.
RIT is the first to directly hold a tokenised economic interest in digital security form however, according
Align Capital Partners (ACP) has made a growth capital investment in WilliamsMarston, an accounting advisory and management consulting firm with offices in Boston and New York. Co-Founders Landen Williams and Jon Marston will continue to lead the Firm through its next phase of growth.
WilliamsMarston provides public, private equity-backed and pre-IPO companies with specialised consulting services including transaction support in M&A, divestitures, initial public offerings and restructuring as well as technical accounting, interim management and process improvement. “Jon and I founded WilliamsMarston on the premise that many companies, their investors, lenders and other stakeholders were underserved in the accounting advisory space,”
Oppenheimer & Co, an investment bank, wealth manager and a subsidiary of Oppenheimer Holdings, has appointed Jarl Berntzen as a managing director in the firm’s Global Technology Investment Banking Group with a primary focus on providing strategic advisory services to companies in the vertical SaaS and data services markets. Berntzen will be based in San Francisco, reporting to Robin Graham, Head of Technology, Media, and Communications Investment Banking. Berntzen is another addition to an extensive list of experienced investment banking professionals recently hired to cover the software sector.
”We’re extremely pleased to welcome Jarl to our Global Technology franchise. His
IQ Capital has led a GBP 5.5 million series A funding round in CyberSmart, which helps small to medium-sized businesses combat cyber-attacks.
The fresh capital will be used to fund CyberSmart’s growth, which has seen an increase in demand with a revenue increase of 300 per cent over the past 12 months, as the lockdown accelerated the use of its cloud-based technology, according to the company.
“We are delighted to have closed our Series A funding round with GBP 5.5 million to fund our next stage of growth. Our investors have seen that we have built a great technology and
iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, has raised an additional EUR5.1 million bringing its total Series A financing to EUR20.1 million. New investor 3B Future Health Fund, previously known as Helsinn Investment Fund, SICAR joins the existing blue chip investor syndicate of M Ventures, INKEF Capital, VI Partners, and Schroder Adveq, which all participated in the extension.
The funding will enable iOnctura to accelerate development of its next generation dual immune and tumour targeting therapies. Data emerging from early clinical evaluation of its lead molecule IOA-244, a highly selective
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
